ASCO Annual Meeting Attendance Tops 25,000, Continuing Fast Growth.
Lung Cancer Gets Less Press, Study Finds
Vanderbilt Wins Lung Cancer SPORE Grant.
Vanderbilt, Jonsson Centers Win NCI SPORE Grants.
Prevention Trials Should Get More Funding, Coltman Says.
FDA Approves Gleevec In 73 Days, A Speed Record.
Pesticides Not Linked To High Rates Of Breast Cancer.
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In the Headlines: Missing record of NCAB meetings restored to NIH website
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”